title: Retrievability of uncoated versus paclitaxel-coated Günther-Tulip IVC filters in an animal model.
abstract: OBJECTIVE
  To compare in a pilot study, the retrievability and inferior vena cava (IVC) wall reaction elicited by uncoated and paclitaxel-coated Günther-Tulip filters in the animal model.
  
  
  METHODS
  Three groups with five pigs each underwent infrarenal IVC implantation of Günther-Tulip filters. Paclitaxel-coated filters were used in Groups A and B and uncoated filters were used in Group C. Filters were removed at 14, 19, 22, 26, and 30 days after implantation. A laparotomy was performed to remove filters from animals in group A and filters from animals in groups B and C that could not be retrieved via the right transjugular approach. Filter-induced venous wall changes were evaluated by examination of IVC venography, feasibility of filter removal at different implantation times, and laparotomy and microscopic findings. Feasibility of filter retrieval and venous wall changes were correlated.
  
  
  RESULTS
  IVC cavography showed no abnormality. Filters in animals in group B were uneventfully removed by a right jugular approach. Uncoated filter removal was not feasible in three of five animals in group C (19, 22, and 26 days). Microscopically, animals in group A had absent filter-induced IVC wall changes at 14, 19, 22, and 26 days and minimal changes at 30 days post implantation; animals in group B had absent filter-induced IVC wall changes at 14, 19, and 22 days and minimal changes at 26 and 30 days; animals in group C had moderate filter-induced IVC wall changes at 14 days and severe changes at 19, 22, 26, and 30 days.
  
  
  CONCLUSIONS
  This pilot study suggests that endothelial reaction to the presence of IVC filters in the porcine model is diminished by addition of paclitaxel coating to these filters. Further studies are necessary to substantiate these results.
authors.affiliation: Interventional Radiology Section, Institute of Minimally-Invasive Techniques, University of Zaragoza, Zaragoza, Spain. madgariza@hotmail.com
authors.forename: Miguel Angel
authors.initials: MA
authors.lastname: De Gregorio
authors.forename: María José
authors.initials: MJ
authors.lastname: Gimeno
authors.forename: Fernando
authors.initials: F
authors.lastname: Lostalé
authors.forename: Pablo
authors.initials: P
authors.lastname: Iñigo
authors.forename: María Consuelo
authors.initials: MC
authors.lastname: Artigas
authors.forename: Américo
authors.initials: A
authors.lastname: Viloria
authors.forename: Eduardo Ramón
authors.initials: ER
authors.lastname: Alfonso
authors.forename: Horacio
authors.initials: H
authors.lastname: D'Agostino
mesh_terms: D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage*; D020099:Coated Materials, Biocompatible; D020878:Device Removal / Q000379:methods*; D008297:Male; D023421:Models, Animal; D017239:Paclitaxel / Q000008:administration & dosage*; D010865:Pilot Projects; D013552:Swine; D016306:Vena Cava Filters / Q000009:adverse effects; D014682:Vena Cava, Inferior
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D020099:Coated Materials, Biocompatible; D017239:Paclitaxel